NCT00777114 Phase 1 Study of Radiosensitization Using Bortezomib in Relapsed Non-Hodgkin's Lymphoma Patients Receiving Radioimmunotherapy Status COMPLETED Phase PHASE1
NCT00776919 Trial of Clindamycin / Benzoyl Peroxide Gel in Subjects With Acne Status COMPLETED Phase PHASE3
NCT00774995 Immune Response of Healthy Subjects Who Received Neonatal Vaccination Course With Engerix™-B Vaccine. Status COMPLETED Phase PHASE4
NCT00772889 Evaluation of the Safety and Immunogenicity of the Influenza Vaccine GSK2186877A in the Elderly Status COMPLETED Phase PHASE3
NCT00771914 The Effects of Omega-3 Fatty Acids on Aspirin Resistance Status COMPLETED Phase PHASE1/PHASE2
NCT00771615 Immunogenicity & Safety of GSK's Avian Flu Vaccine 1557484A Given to Adults Aged 18-64 Years Status COMPLETED Phase PHASE2
NCT00766090 Safety and Efficacy of GW685698X an Inhaled Corticosteroid Once Daily and Twice Daily for the Treatment of Asthma Status COMPLETED Phase PHASE2
NCT00765076 Clinical Study of the Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2186877A in People Aged 65 Years or Older Status COMPLETED Phase PHASE3
NCT00764790 Immunogenicity and Safety of GSK Biologicals' Influenza Vaccine Versus a Licensed Comparator in Children Status COMPLETED Phase PHASE3
NCT00764465 An Interaction Study to Assess Drug Levels in Healthy Adult Subjects Status COMPLETED Phase PHASE2
NCT00760617 Evaluation of Safety and Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2186877A in Adults 65 Years and Older Status COMPLETED Phase PHASE3
NCT00758264 Co-administration of Meningococcal Vaccine GSK134612 and Pneumococcal Vaccine GSK1024850A vs Individual Administration Status COMPLETED Phase PHASE3
NCT00757770 Assessment of Clinical Consistency of Three Production Lots of GSK Biologicals' HRV Vaccine Status COMPLETED Phase PHASE3
NCT00757523 Evaluation of the Effectiveness, Safety, and Tolerability of Duac Akne Gel and Epiduo Gel in the Treatment of Facial Acne Vulgaris Status COMPLETED Phase PHASE4
NCT00753688 Pazopanib Versus Placebo in Patients With Soft Tissue Sarcoma Whose Disease Has Progressed During or Following Prior Therapy Status COMPLETED Phase PHASE3
NCT00753649 Immunogenicity and Safety of GSK Biologicals' Infanrix Hexa in Infants Status COMPLETED Phase PHASE4